WallStreetZenWallStreetZen

NASDAQ: IOVA
Iovance Biotherapeutics Inc Stock Ownership - Who owns Iovance Biotherapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Iovance Biotherapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Frederick G. VogtInterim CEO General Counsel2026-03-0526,755$4.58
$122.54kSell
Raj K. PuriChief Regulatory Officer2026-03-0518,360$4.58
$84.09kSell
Igor BilinskyChief Operating Officer2026-03-0516,628$4.58
$76.16kSell
Finckenstein Friedrich GrafChief Medical Officer2026-03-0516,520$4.58
$75.66kSell
Raj K. PuriChief Regulatory Officer2026-03-022,798$3.79
$10.60kSell
Frederick G. VogtInterim CEO General Counsel2026-03-0222,809$3.79
$86.45kSell
Finckenstein Friedrich GrafChief Medical Officer2026-03-027,122$3.79
$26.99kSell
Igor BilinskyChief Operating Officer2026-03-026,903$3.79
$26.16kSell
Daniel Gordon KirbyChief Commercial Officer2026-02-2434,165$3.78
$129.14kSell
Daniel Gordon KirbyChief Commercial Officer2026-02-1016,450$2.60
$42.77kSell

1 of 3

IOVA insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when IOVA insiders and whales buy or sell their stock.

IOVA Shareholders

What type of owners hold Iovance Biotherapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Ayer Capital Management LP136.72%563,224,483$2.93BInsider
Paul L. Kessler100.88%415,566,430$2.16BInsider
Blackrock Inc7.17%29,518,125$153.49MInstitution
Mhr Fund Management LLC7.03%28,967,103$150.63MInstitution
Wayne P. Rothbaum6.81%28,067,333$145.95MInsider
Vanguard Group Inc6.60%27,207,079$141.48MInstitution
Atlantic Hamilton5.09%20,960,016$108.99MInsider
State Street Corp4.89%20,161,445$104.84MInstitution
David J. Voyticky4.61%18,981,082$98.70MInsider
Bank Of America Corp3.47%14,277,813$74.24MInstitution

1 of 3

IOVA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
IOVA19.44%80.56%Net SellingNet Selling
MESO0.32%0.00%
SLNO35.50%64.50%Net SellingNet Selling
AUPH54.35%13.23%Net BuyingNet Buying
TYRA62.55%37.45%Net BuyingNet Selling
View Top Biotech Stocks

Iovance Biotherapeutics Stock Ownership FAQ

Who owns Iovance Biotherapeutics?

Iovance Biotherapeutics (NASDAQ: IOVA) is owned by 63.50% institutional shareholders, 263.22% Iovance Biotherapeutics insiders, and 0.00% retail investors. Ayer Capital Management LP is the largest individual Iovance Biotherapeutics shareholder, owning 563.22M shares representing 136.72% of the company. Ayer Capital Management LP's Iovance Biotherapeutics shares are currently valued at $2.73B.

If you're new to stock investing, here's how to buy Iovance Biotherapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.